ID: MRFR/MED/4104-HCR | 200 Pages | Published By Kinjoll Dey on March 2023
The hallux rigidus market is anticipated to reach USD 8.57 Billion by 2030 at 7.60% CAGR during the forecast period 2022-2030. Hallux rigidus is an arthritic condition often leading to pain and stiffness within the joint located behind the big toe. Hallux rigidus is a syndrome related to degeneration of the first MTP joint. It leads to a limitation in joint range of motion and painful ambulation.
Hallux rigidus can be caused by either a traumatic injury or through overuse of the foot. Overpronation or too much stress on the joint is one of the reasons. Repetitive weight bearing in a dorsiflexed position such as when walking up mountains or driving forward in a rugby scrum or similar conditions can be a factor.
Other causes include traumatic injury such as stubbing the big toe causing cartilage damage in the joint. Rheumatoid arthritis which is inflammatory wear and tear of the joint, as well as gout which is a form of arthritis caused by excessive uric acid in the joint, can also cause hallux rigidus.
The hallux rigidus market is majorly driven by increasing geriatric population, rising diabetic mass, and rising road mishaps. According to the U.S. Population Reference Bureau, the number of Americans aged 65 and older is projected to 98 million by 2060 from 46 million as of 2014. Similarly, the 65-and-older age group will rise to nearly 24 percent by 2030 from 15 percent as of 2015.
The hallux rigidus infection market is segmented on the basis of treatment, diagnosis, and end-users.
On the basis of the treatment, the market is segmented into non-surgical treatment and surgical treatment. Further, the non-surgical treatment is sub-segmented into shoe modifications, orthotic devices, medications, injection therapy, and physical therapy. And the surgical treatment is sub-segmented into bone spur removal (cheilectomy), joint fusion (arthrodesis), joint resurfacing (interpositional arthroplasty), and joint replacement (arthroplasty).
On the basis of diagnosis, the Hallux Rigidus Market is segmented into X-ray, CT scan, and MRI.
On the basis of the end users, the market is segmented into hospitals & surgical centers, home cares, and orthopedic specialty clinics.
North America holds the maximum share of hallux rigidus market in the Americas region. On a regional basis, Americas region is segmented into North America and South America. North America is segmented into the U.S. and Canada. Increasing number of geriatric population and growing diabetic mass has increased the scope of the market in North America.
Europe holds the second largest share in the market. The European market is expected to observe a healthy growth during the forecasted period. Factors such as availability of advanced treatment facilities, and skilled medical professionals is propelling the growth of hallux rigidus market in Europe. Additionally, increasing government funding and extensive research and development in terms of healthcare is likely to boost the market growth.
Asia Pacific is expected to be the fastest growing market owing to increasing prevalence of chronic diseases such as diabetes is the major driver for the market growth. India is the fastest growing region owing to an increasing population. Rising awareness about the health and availability of new treatment methods is likely to drive the market in this region.
The Middle East & Africa is expected to show a slow growth in the market . Major factors that are hampering the growth are lack of awareness, and limited access and availability of treatment facilities. In the Middle East, United Arab Emirates has garnered the largest market share owing to the development of healthcare industry and rising number of specialty care centers.
Some of the key players in Hallux Rigidus Market are DePuy Synthes Companies, Stryker, Zimmer Biomet, Smith & Nephew, Wright Medical Group N.V., Advanced Orthopaedic Solutions, Integra LifeSciences Corporation, and Acumed, Bioretec Ltd. among others.
Hallux rigidus is an arthritic condition often leading to pain and stiffness within the joint located behind the big toe. Hallux rigidus is a syndrome related to degeneration of the first MTP joint and leads to a limitation in the range of motion and painful ambulation.
The market is expected to exhibit a strong 7.60% CAGR over the forecast period from 2022-2030.
The increasing geriatric population is likely to be a major driver for the hallux rigidus market.
The Americas hold a majority share in the Hallux Rigidus Market.
Leading players in the hallux rigidus market include Stryker, Zimmer Biomet, and Smith & Nephew, among others.